Hartwick has hired Alice Ceacareanu as the new TBRM program director. She joined the college on Jan. 7. Every institution of higher education has the responsibility to assess, from time to time, how best to meet the needs of learners as they “navigate emerging, expanding and maturing industries,” Hartwick College President Margaret Drugovich said in […]
Hartwick has hired Alice Ceacareanu as the new TBRM program director. She joined the college on Jan. 7.
Every institution of higher education has the responsibility to assess, from time to time, how best to meet the needs of learners as they “navigate emerging, expanding and maturing industries,” Hartwick College President Margaret Drugovich said in a release.
“This master’s program will prepare professionals to make pivotal contributions to the growing biomedical and bio-pharmaceutical industry. This program will both launch and advance careers, providing new opportunities for professional success. We appreciate the support and encouragement of the New York State Education Department as we prepared to open this program,” she added.
About the program
The TBRM program will be offered cohort-style, with groups of students starting and progressing through the program together in sequence.
The two-year curriculum includes four semesters of traditional study, and experiential training via internships and clinical trials in the summer. Coursework will focus on areas including epidemiology, biostatistics and informatics, and molecular genetics and personalized medicine.
The new program is “ideal” for students with bachelor’s degrees in the natural/social sciences or health professions; those with good oral and written-communication skills; and those who hold entry-level professional positions in clinical/applied research and development, the college contends.
The program is also for people with advanced professional degrees, such as doctorates in business, nursing, or public health. TBRM students may not necessarily plan to pursue a doctoral degree, the school noted.
About Ceacareanu
The new TBRM program director, Ceacareanu, has relocated to Oneonta from Buffalo for her new position at Hartwick, David Lubell, media-relations manager at Hartwick College, said in an email reply to a CNYBJ inquiry.
She had founded and served as president of ROAKETIN, Inc., a health-care consultancy, but has since departed the company for the Hartwick position, he added.
Ceacareanu also previously served as an assistant professor of pharmacy practice and adjunct professor of pharmaceutical sciences for the University at Buffalo.
For nine years, she served also as an oncology clinical pharmacist at the Roswell Park Cancer Institute in Buffalo.
Ceacareanu has been published extensively, earned multiple awards for her research, teaching and mentorship, and been awarded several grants and patents, Hartwick College said.
